Emerging as a noteworthy breakthrough in the battle against obesity, this medication is generating considerable interest . This treatment combines properties of two known GLP-1 binding agonists, liraglutide, and an new glucose-dependent peptide component. Initial study findings have shown substantial weight decrease in people with obesity , perh… Read More